IncFact
Company Profiles: Revenue, Growth, Competition

Asclepix Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Asclepix Therapeutics

Access the complete profile.

Asclepix Therapeutics Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes541711 Research & Development in Biotechnology
Address301 W 29th St
Ste 2004
Baltimore, MD 21211

Note: Revenues for privately held companies are statistical evaluations.


Asclepix Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Asclepix Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Asclepix Therapeutics Annual Revenue and Growth Rate

Asclepix Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $1 - $10 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Asclepix Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Asclepix Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
April 26, 2024 9 80%$13 MM
Complete list of funding rounds and total amounts in the Company Report




Asclepix Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Asclepix Therapeutics Revenue (Sales) Asclepix Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Market Share of Asclepix Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Asclepix Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Asclepix Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
PGDXBaltimore, MD100 
LIEBER INSTITUTEBaltimore, MD34 
PERSONAL GENOME DIAGNOSTICSBaltimore, MD30 
MARITIME APPLIED PHYSICSCurtis Bay, MD16 
FRIENDS RESEARCH INSTITUTEBaltimore, MD15 
RCT SYSTEMSBaltimore, MD14 




Future Competition: Asclepix Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Asclepix Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Asclepix Therapeutics Competitors